| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CCDC170 EPS8 MYH3 XIRP1 CEACAM5 CENPF SYNE1 KTN1 CEP290 OBSCN TOGARAM1 SPAG9 LMOD2 SPC24 CCDC88C SETD2 CCDC88A DST XIRP2 TUBGCP3 SYN1 MACF1 MYH15 CTNNA2 TBCEL | 9.30e-06 | 1099 | 173 | 25 | GO:0008092 |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 2.69e-04 | 15 | 173 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | actin binding | EPS8 MYH3 XIRP1 CEACAM5 SYNE1 LMOD2 CCDC88A DST XIRP2 SYN1 MACF1 MYH15 CTNNA2 | 2.87e-04 | 479 | 173 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | microtubule binding | CCDC170 CENPF CEP290 TOGARAM1 SPC24 CCDC88C CCDC88A DST TUBGCP3 MACF1 | 3.66e-04 | 308 | 173 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | tubulin binding | CCDC170 CENPF CEP290 TOGARAM1 SPC24 CCDC88C SETD2 CCDC88A DST TUBGCP3 MACF1 TBCEL | 3.67e-04 | 428 | 173 | 12 | GO:0015631 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 5.22e-07 | 36 | 174 | 6 | GO:0035459 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | CTAGE9 GOPC GOSR2 MIA2 USO1 CTAGE1 CTAGE8 CTAGE15 CTAGE4 STX17 | 1.02e-06 | 159 | 174 | 10 | GO:0006888 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPS8 CFAP91 RAB17 PDGFRB SYNE1 CEP290 TRPM2 KIAA0586 TOGARAM1 SRGAP2 ALPK1 TBC1D32 CCDC88A PTPRO MTOR CEP250 FGD1 TEKT4 | 1.54e-05 | 670 | 174 | 18 | GO:0120031 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPS8 CFAP91 RAB17 PDGFRB SYNE1 CEP290 TRPM2 KIAA0586 TOGARAM1 SRGAP2 ALPK1 TBC1D32 CCDC88A PTPRO MTOR CEP250 FGD1 TEKT4 | 2.07e-05 | 685 | 174 | 18 | GO:0030031 |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | MYH3 XIRP1 CEACAM5 PDGFRB SYNE1 OBSCN SPAG9 LMOD2 PTGFRN BMP2 MTOR MYOM2 HOMER1 | 2.90e-05 | 391 | 174 | 13 | GO:0051146 |
| GeneOntologyBiologicalProcess | myofibril assembly | 8.89e-05 | 86 | 174 | 6 | GO:0030239 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 XIRP1 CFAP91 RAB17 CENPF PDGFRB SYNE1 CEP290 KIAA0586 OBSCN TOGARAM1 ALPK1 LMOD2 TBC1D32 CCDC88A MDN1 MTOR CEP250 TUBGCP3 TEKT4 MYOM2 STX17 KNL1 | 9.01e-05 | 1138 | 174 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 1.08e-04 | 89 | 174 | 6 | GO:0055002 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.40e-04 | 59 | 174 | 5 | GO:0045214 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | CTAGE9 GOPC GOSR2 MIA2 USO1 CTAGE1 CTAGE8 CTAGE15 MACF1 CTAGE4 STX17 | 1.49e-04 | 339 | 174 | 11 | GO:0048193 |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH3 XIRP1 CEACAM5 PDGFRB SYNE1 OBSCN SPAG9 LMOD2 PTGFRN BMP2 MTOR ZBED6 MYOM2 HOMER1 | 1.72e-04 | 531 | 174 | 14 | GO:0042692 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 1.29e-06 | 42 | 175 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | myosin filament | 5.23e-05 | 25 | 175 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myofibril | 1.06e-04 | 273 | 175 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 1.55e-04 | 13 | 175 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.73e-04 | 290 | 175 | 10 | GO:0043292 | |
| Domain | Actin-binding_Xin_repeat | 8.04e-05 | 2 | 168 | 2 | IPR012510 | |
| Domain | XIRP1/XIRP2 | 8.04e-05 | 2 | 168 | 2 | IPR030072 | |
| Domain | XIN | 8.04e-05 | 2 | 168 | 2 | PS51389 | |
| Domain | Xin | 8.04e-05 | 2 | 168 | 2 | PF08043 | |
| Domain | Transcrp_activ_Zfx/Zfy-dom | 2.40e-04 | 3 | 168 | 2 | IPR006794 | |
| Domain | Zfx_Zfy_act | 2.40e-04 | 3 | 168 | 2 | PF04704 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 1.53e-05 | 36 | 125 | 5 | MM15300 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | CTAGE9 UAP1 CEACAM5 RAB17 TNC USP28 TNIP2 KTN1 CHML GOSR2 NUP205 UBA1 THRB MIA2 STC2 USO1 ICMT CTAGE1 RGPD3 MDC1 CTAGE8 ST8SIA2 CTBP1 RNF128 STX17 HCFC1 USP33 | 6.94e-05 | 1389 | 125 | 27 | MM15307 |
| Pubmed | DNAJC13 CENPF USP28 SYNE1 KTN1 SRGAP2 UBN2 CCDC177 TRIM3 AKAP12 CEP170 CCDC88C TXLNA UBA1 CCDC88A SNW1 DST MDN1 MTOR RGPD3 PDE4DIP SYN1 MACF1 CTBP1 CTNNA2 FRMPD3 HOMER1 GOLGA3 ANKS1A | 1.40e-14 | 963 | 177 | 29 | 28671696 | |
| Pubmed | ATP5PB MYH3 MACC1 CENPF SYNE1 LIN54 KTN1 ANKRD26 ECE1 DNTTIP2 NUP205 MIPOL1 LIG4 DST MDN1 MIA2 UMODL1 CTAGE1 RGPD3 CTAGE8 CFAP45 MARF1 CTAGE15 MACF1 MYH15 BOD1L1 CHD6 MYOM2 CTAGE4 SIPA1L2 CCDC89 BAHCC1 | 2.06e-12 | 1442 | 177 | 32 | 35575683 | |
| Pubmed | TET2 DNAJC13 HIVEP1 CENPF LIN54 CCDC88A TBC1D4 DST GSE1 USO1 RGPD3 CTBP1 RAI14 CHD6 NXF1 GOLGA3 KNL1 | 5.96e-11 | 418 | 177 | 17 | 34709266 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CDK12 USP28 KTN1 ANKRD26 BAZ1B SPAG9 SRGAP2 DNTTIP2 AKAP12 CEP170 SPC24 SETD2 IARS2 UBA1 SNW1 DST GSE1 MACF1 RAI14 BOD1L1 SIPA1L2 HCFC1 KNL1 ANKS1A | 8.53e-11 | 934 | 177 | 24 | 33916271 |
| Pubmed | MYH3 HIVEP1 SYNE1 KTN1 OBSCN ANKRD26 ELP1 DNTTIP2 AKAP12 CEP170 TBC1D4 DST GSE1 XIRP2 TUBGCP3 PDE4DIP MACF1 MYOM2 | 1.05e-10 | 497 | 177 | 18 | 23414517 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EPS8 KRT9 HIVEP1 USP28 ZNF180 LIN54 ANKRD26 ELP1 BAZ1B UBN2 SETD2 CCDC88A TBC1D4 GSE1 USO1 MACF1 SIPA1L2 NXF1 KNL1 | 2.11e-10 | 588 | 177 | 19 | 38580884 |
| Pubmed | TET2 SEMA4D CFAP91 PDGFRB USP28 SYNE1 CEP290 APBA2 SRGAP2 QRICH1 USP9Y ME3 MIPOL1 VPS9D1 DST MIA2 PDE4DIP MACF1 CTBP1 RAI14 ANKRD24 CHD6 MLST8 MVP GOLGA3 USP33 BRWD1 | 4.47e-10 | 1285 | 177 | 27 | 35914814 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 UAP1 HIVEP1 ANKRD26 SRGAP2 ALPK1 TAB3 CEP170 CCDC88C CCDC88A TBC1D4 DST MDN1 USO1 MTOR SRGAP1 MACF1 RAI14 BOD1L1 SIPA1L2 TNPO3 ANKS1A | 6.17e-10 | 861 | 177 | 22 | 36931259 |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 6.48e-10 | 4 | 177 | 4 | 27311593 | |
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 6.48e-10 | 4 | 177 | 4 | 33718348 | |
| Pubmed | 6.48e-10 | 4 | 177 | 4 | 12586826 | ||
| Pubmed | 6.48e-10 | 4 | 177 | 4 | 31244610 | ||
| Pubmed | 6.48e-10 | 4 | 177 | 4 | 21807889 | ||
| Pubmed | KTN1 CEP290 KIAA0586 ANKRD26 TOGARAM1 SPAG9 ALPK1 UBN2 PTGFRN FCHO1 ABCA8 CEP170 CCDC88C SETD2 MACF1 ANKRD24 PCDH18 | 7.47e-10 | 493 | 177 | 17 | 15368895 | |
| Pubmed | 3.23e-09 | 5 | 177 | 4 | 19131326 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 3.23e-09 | 5 | 177 | 4 | 12839582 | |
| Pubmed | 3.23e-09 | 5 | 177 | 4 | 18630941 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 3.23e-09 | 5 | 177 | 4 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 3.23e-09 | 5 | 177 | 4 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 3.23e-09 | 5 | 177 | 4 | 21183079 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | DNAJC13 HIVEP1 CDK12 TNIP2 TOGARAM1 TEX11 ECE1 FCHO1 MIPOL1 CEP170 GSE1 MDC1 MACF1 NXF1 | 5.72e-09 | 361 | 177 | 14 | 26167880 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | CENPF CDK12 KTN1 TRIM3 CEP170 SNW1 DST SYN1 MACF1 CTBP1 BOD1L1 CTNNA2 HCFC1 TNPO3 NXF1 ANKS1A | 6.56e-09 | 498 | 177 | 16 | 36634849 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.20e-08 | 120 | 177 | 9 | 31413325 | |
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 2.24e-08 | 7 | 177 | 4 | 29133483 | |
| Pubmed | EPS8 GOPC ANKRD26 SRGAP2 PLXNB2 AKAP12 IARS2 CCDC88A DST MACF1 CTBP1 RAI14 SIPA1L2 GOLGA3 | 3.92e-08 | 421 | 177 | 14 | 36976175 | |
| Pubmed | ATP5PB DNAJC13 GOPC SYNE1 KTN1 ANKRD26 ELP1 BAZ1B CHCHD6 GOSR2 PLXNB2 DNTTIP2 AKAP12 TXLNA AIFM2 IARS2 CCDC88A SNW1 MDN1 DNAJC28 TUBGCP3 MRPS11 MACF1 SIPA1L2 GOLGA3 USP33 | 4.13e-08 | 1487 | 177 | 26 | 33957083 | |
| Pubmed | A Conserved Role for Girdin in Basal Body Positioning and Ciliogenesis. | 4.47e-08 | 8 | 177 | 4 | 27623382 | |
| Pubmed | 4.70e-08 | 20 | 177 | 5 | 21689717 | ||
| Pubmed | CENPF ELP1 BAZ1B SPAG9 DNTTIP2 NUP205 CEP170 IARS2 SNW1 DST MDN1 MTOR MDC1 MACF1 MVP HCFC1 NXF1 | 4.72e-08 | 653 | 177 | 17 | 22586326 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | CFAP91 DNAJC13 GOPC CNOT10 KTN1 CEP290 CHCHD6 SPAG9 SRGAP2 AKAP12 NUP205 MIPOL1 CEP170 TBC1D32 TXLNA UBA1 CCDC88A TBC1D4 MTOR MARF1 CTBP1 RAI14 MLST8 TNPO3 | 7.16e-08 | 1321 | 177 | 24 | 27173435 |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 8.01e-08 | 9 | 177 | 4 | 18342301 | |
| Pubmed | 8.86e-08 | 151 | 177 | 9 | 17043677 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | GOPC USP28 TNIP2 LIN54 KTN1 SPAG9 QRICH1 CREM TRIM3 NUP205 TBC1D32 LIG4 IARS2 RNASEL TBC1D4 MDN1 GSE1 USO1 HCFC1 | 9.18e-08 | 857 | 177 | 19 | 25609649 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RETREG2 CENPF ACOT9 CNOT10 SYNE1 LIN54 BPIFB1 CHCHD6 SPAG9 AKAP12 CEP170 SPC24 UBA1 SNW1 RGPD3 TUBGCP3 SMARCD1 RAI14 HCFC1 HOMER1 NXF1 KNL1 | 1.18e-07 | 1155 | 177 | 22 | 20360068 |
| Pubmed | KIAA0586 HELB CCDC88A TBC1D4 DST USO1 MACF1 SIPA1L2 GOLGA3 ANKS1A | 1.33e-07 | 209 | 177 | 10 | 36779422 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KRT9 DNAJC13 CDK12 SYNE1 USP9Y NUP205 CEP170 SETD2 SNW1 DST PTPRO TUBGCP3 CFAP45 MRPS11 SMARCD1 MACF1 CTBP1 CHD6 SIPA1L2 MVP NXF1 | 1.72e-07 | 1082 | 177 | 21 | 38697112 |
| Pubmed | GOPC CDK12 KTN1 CEP290 SRGAP2 CEP170 SETD2 IARS2 CCDC88A USO1 MDC1 BOD1L1 CHD6 HCFC1 USP33 KNL1 ANKS1A | 2.42e-07 | 733 | 177 | 17 | 34672954 | |
| Pubmed | CDK12 ACOT9 ELP1 ECE1 LIG4 TXLNA AIFM2 CCDC88A DST GSE1 TUBGCP3 MARF1 RNF128 HCFC1 NXF1 USP33 | 2.53e-07 | 650 | 177 | 16 | 38777146 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CCDC170 MYH3 CENPF KTN1 CEP290 OBSCN SPAG9 CHML NUP205 MIPOL1 TBC1D4 DST MDN1 GSE1 BOD1L1 CHD6 NXF1 | 2.56e-07 | 736 | 177 | 17 | 29676528 |
| Pubmed | Interaction network of human early embryonic transcription factors. | SOX5 TET2 HIVEP1 LIN54 BAZ1B UBN2 GSE1 MDC1 SMARCD1 CTBP1 MLST8 BAHCC1 | 2.82e-07 | 351 | 177 | 12 | 38297188 |
| Pubmed | ATP5PB SOX5 TET2 HIVEP1 CNOT10 TNIP2 LIN54 BAZ1B SPAG9 UBN2 TAB3 NUP205 SNW1 DST GSE1 MDC1 MARF1 MRPS11 SMARCD1 CTBP1 RAI14 CHD6 HCFC1 NXF1 | 3.00e-07 | 1429 | 177 | 24 | 35140242 | |
| Pubmed | XIRP1 HIVEP1 SYNE1 QRICH1 AKAP12 DST XIRP2 PDE4DIP RAI14 USP33 | 3.63e-07 | 233 | 177 | 10 | 37704626 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EPS8 KRT9 ACOT9 CEP290 ANKRD26 ECE1 TAB3 NUP205 MIPOL1 SPC24 CCDC88C TXLNA IARS2 CCDC88A CEP250 SIPA1L2 ANKS1A BRWD1 | 4.19e-07 | 853 | 177 | 18 | 28718761 |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 4.47e-07 | 13 | 177 | 4 | 11839810 | |
| Pubmed | EPS8 CNOT10 ANKRD26 ELP1 SRGAP2 MIPOL1 CEP170 CCDC88C TBC1D4 DST SMARCD1 SIPA1L2 ANKS1A | 5.44e-07 | 446 | 177 | 13 | 24255178 | |
| Pubmed | EPS8 MACC1 CEACAM5 CDK12 CNOT10 SYNE1 KTN1 BAZ1B SRGAP2 UBN2 HARS2 SETD2 DST MDN1 CGREF1 ZBED6 RGPD3 MDC1 MACF1 CTBP1 RAI14 CHD6 CTNNA2 NXF1 | 6.88e-07 | 1497 | 177 | 24 | 31527615 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 8.47e-07 | 15 | 177 | 4 | 14762062 | |
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 8.47e-07 | 15 | 177 | 4 | 30224460 | |
| Pubmed | LRRC45 CEP290 KIAA0586 ANKRD26 CEP170 CEP250 TUBGCP3 PDE4DIP | 8.90e-07 | 146 | 177 | 8 | 21399614 | |
| Pubmed | CDK12 KTN1 BAZ1B SPAG9 UBN2 TAB3 CEP170 SETD2 UBA1 SNW1 MDC1 RAI14 BOD1L1 HCFC1 | 9.68e-07 | 549 | 177 | 14 | 38280479 | |
| Pubmed | ATP5PB EPS8 DNAJC13 TNC SYNE1 KTN1 ELP1 SRGAP2 CCDC177 TRIM3 CEP170 UBA1 DST USO1 PDE4DIP SYN1 MACF1 CTBP1 RAI14 CTNNA2 SIPA1L2 HOMER1 GOLGA3 | 1.15e-06 | 1431 | 177 | 23 | 37142655 | |
| Pubmed | 1.30e-06 | 268 | 177 | 10 | 33640491 | ||
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 1.88e-06 | 18 | 177 | 4 | 11149944 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SEMA4D DNAJC13 RAB17 TRPM2 OBSCN CHCHD6 ZNF385B SRGAP2 UBN2 PCDHB16 MIPOL1 HIPK3 CEP170 TBC1D4 THRB MACF1 CTBP1 RAI14 BOD1L1 ANKRD24 CHD6 STX17 ANKS1A | 2.24e-06 | 1489 | 177 | 23 | 28611215 |
| Pubmed | ATP5PB KRT9 DNAJC13 PDGFRB CNOT10 KTN1 CEP290 ECE1 GOSR2 NUP205 TXLNA MDN1 MIA2 USO1 MTOR TUBGCP3 MARF1 MVP HCFC1 GOLGA3 | 2.37e-06 | 1168 | 177 | 20 | 19946888 | |
| Pubmed | 2.37e-06 | 19 | 177 | 4 | 24421332 | ||
| Pubmed | KRT9 DNAJC13 GOPC LIN54 ANKRD26 PCDHB2 SPAG9 AKAP12 IARS2 CCDC88A DST USO1 ZBED6 CTBP1 RAI14 GOLGA3 | 2.59e-06 | 777 | 177 | 16 | 35844135 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB HIVEP1 CENPF PDGFRB SYNE1 KTN1 KIAA0586 ELP1 BAZ1B DNTTIP2 NUP205 TXLNA IARS2 UBA1 SNW1 MDN1 USO1 MTOR MDC1 BOD1L1 HCFC1 NXF1 | 3.83e-06 | 1425 | 177 | 22 | 30948266 |
| Pubmed | 4.47e-06 | 7 | 177 | 3 | 7928394 | ||
| Pubmed | An evaluation of the inactive mouse X chromosome in somatic cell hybrids. | 4.47e-06 | 7 | 177 | 3 | 8460399 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DNAJC13 ACOT9 CNOT10 KTN1 ANKRD26 SRGAP2 UBN2 AKAP12 CEP170 TXLNA UBA1 SNW1 MARF1 MACF1 NXF1 | 5.02e-06 | 724 | 177 | 15 | 36232890 |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 5.42e-06 | 132 | 177 | 7 | 16944949 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | CEP290 SRGAP2 AKAP12 CEP170 AIFM2 CCDC88A TBC1D4 SNW1 CEP250 TUBGCP3 MRPS11 CTNNA2 SIPA1L2 GOLGA3 | 5.59e-06 | 639 | 177 | 14 | 23443559 |
| Pubmed | ATP5PB CNOT10 CEP290 ANKRD26 SPAG9 UBN2 CEP170 SPC24 TXLNA DST CTBP1 RAI14 CHD6 HOMER1 | 6.21e-06 | 645 | 177 | 14 | 25281560 | |
| Pubmed | GOPC CEP170 SETD2 TXLNA UBA1 TBC1D4 SNW1 MDC1 CTBP1 BOD1L1 HCFC1 | 7.03e-06 | 399 | 177 | 11 | 35987950 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | CENPF ACOT9 USP28 CEP290 TRIM3 MIPOL1 CEP170 MDN1 STC2 MTOR CEP250 TUBGCP3 PDE4DIP TNPO3 GOLGA3 | 8.14e-06 | 754 | 177 | 15 | 33060197 |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 8.41e-06 | 331 | 177 | 10 | 19490893 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FILIP1 DNAJC13 HIVEP1 CDK12 BAZ1B SPAG9 ZFX SETD2 UBA1 TBC1D4 MDN1 GSE1 STC2 MDC1 ANKS1A | 1.11e-05 | 774 | 177 | 15 | 15302935 |
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 1.37e-05 | 152 | 177 | 7 | 28192407 | |
| Pubmed | CENPF CNOT10 KIAA0586 ZRANB3 TRIM3 SNW1 SLCO4C1 TUBGCP3 MACF1 | 1.51e-05 | 281 | 177 | 9 | 24163370 | |
| Pubmed | RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain. | 1.51e-05 | 10 | 177 | 3 | 29097665 | |
| Pubmed | 1.74e-05 | 360 | 177 | 10 | 33111431 | ||
| Pubmed | 1.83e-05 | 31 | 177 | 4 | 22261722 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | LIN54 BAZ1B SPAG9 QRICH1 UBN2 DNTTIP2 CEP170 UBA1 SNW1 RGPD3 HCFC1 | 1.90e-05 | 444 | 177 | 11 | 34795231 |
| Pubmed | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. | 2.06e-05 | 162 | 177 | 7 | 14743216 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP5PB CENPF SYNE1 CEP290 ELP1 BAZ1B PLXNB2 DNTTIP2 NUP205 CEP170 UBA1 SNW1 DST MDN1 MDC1 MACF1 NXF1 | 2.09e-05 | 1024 | 177 | 17 | 24711643 |
| Pubmed | 2.16e-05 | 225 | 177 | 8 | 12168954 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 2.40e-05 | 298 | 177 | 9 | 32353859 | |
| Pubmed | BAZ1B is dispensable for H2AX phosphorylation on Tyrosine 142 during spermatogenesis. | 2.58e-05 | 2 | 177 | 2 | 25979708 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28927892 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 33984363 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 20548225 | ||
| Pubmed | Analysis and identification of the Grem2 heparin/heparan sulfate-binding motif. | 2.58e-05 | 2 | 177 | 2 | 28104757 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 11002341 | ||
| Pubmed | Emergence of Xin demarcates a key innovation in heart evolution. | 2.58e-05 | 2 | 177 | 2 | 18682726 | |
| Pubmed | Zfa is an expressed retroposon derived from an alternative transcript of the Zfx gene. | 2.58e-05 | 2 | 177 | 2 | 1691708 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 8188262 | ||
| Pubmed | Isoform-specific interaction of golgin-160 with the Golgi-associated protein PIST. | 2.58e-05 | 2 | 177 | 2 | 15951434 | |
| Pubmed | Mapping the human ZFX locus to Xp21.3 by in situ hybridization. | 2.58e-05 | 2 | 177 | 2 | 2497060 | |
| Pubmed | Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. | 2.58e-05 | 2 | 177 | 2 | 2041734 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 8318216 | ||
| Pubmed | [Expression of Zfx in mouse testicular spermatogenic cells]. | 2.58e-05 | 2 | 177 | 2 | 38602753 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12716983 | ||
| Pubmed | Intron/exon structure confirms that mouse Zfy1 and Zfy2 are members of the ZFY gene family. | 2.58e-05 | 2 | 177 | 2 | 9126493 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28125926 | ||
| Pubmed | BMP Antagonist Gremlin 2 Limits Inflammation After Myocardial Infarction. | 2.58e-05 | 2 | 177 | 2 | 27283840 | |
| Pubmed | Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. | 2.58e-05 | 2 | 177 | 2 | 8487630 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26075789 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 25041854 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26386044 | ||
| Interaction | CTAGE1 interactions | 1.17e-08 | 10 | 176 | 5 | int:CTAGE1 | |
| Interaction | CTAGE4 interactions | 6.55e-07 | 3 | 176 | 3 | int:CTAGE4 | |
| Interaction | YWHAE interactions | TET2 MACC1 UAP1 HIVEP1 CDK12 TNIP2 KTN1 ANKRD26 SRGAP2 TAB3 CEP170 VPS9D1 CCDC88C IARS2 UBA1 CCDC88A TBC1D4 DST MTOR SRGAP1 CEP250 SYN1 MACF1 RAI14 SIPA1L2 HOMER1 GOLGA3 ANKS1A | 4.38e-06 | 1256 | 176 | 28 | int:YWHAE |
| Interaction | NAA40 interactions | CDK12 USP28 KTN1 ANKRD26 BAZ1B SPAG9 SRGAP2 DNTTIP2 AKAP12 CEP170 SPC24 SETD2 IARS2 UBA1 SNW1 DST GSE1 MACF1 RAI14 BOD1L1 SIPA1L2 HCFC1 KNL1 ANKS1A | 4.67e-06 | 978 | 176 | 24 | int:NAA40 |
| Interaction | CTAGE15 interactions | 6.46e-06 | 5 | 176 | 3 | int:CTAGE15 | |
| Interaction | TNIK interactions | CENPF SYNE1 UBN2 TRIM3 CEP170 DST GSE1 PDE4DIP MRPS11 MACF1 CTBP1 CTNNA2 MVP HOMER1 | 6.80e-06 | 381 | 176 | 14 | int:TNIK |
| Interaction | CIAO1 interactions | CENPF KTN1 ELP1 SRGAP2 SPC24 LIG4 MIA2 XIRP2 MRPS11 CTBP1 GOLGA3 KNL1 | 9.37e-06 | 289 | 176 | 12 | int:CIAO1 |
| Interaction | NUP43 interactions | HIVEP1 CDK12 LIN54 UBN2 DNTTIP2 ZFX HELB SETD2 CCDC88A DST GSE1 CEP250 MDC1 MARF1 BOD1L1 CHD6 HCFC1 KNL1 | 9.67e-06 | 625 | 176 | 18 | int:NUP43 |
| Interaction | PHF21A interactions | DNAJC13 HIVEP1 CENPF KRT27 CCDC88A TBC1D4 DST GSE1 USO1 RAI14 CHD6 GOLGA3 KNL1 | 1.05e-05 | 343 | 176 | 13 | int:PHF21A |
| Interaction | YWHAG interactions | TET2 UAP1 HIVEP1 CDK12 TNIP2 ANKRD26 SRGAP2 DNTTIP2 TAB3 CEP170 CCDC88C IARS2 UBA1 CCDC88A TBC1D4 DST MDN1 MTOR SRGAP1 CEP250 SMARCD1 MACF1 RAI14 BOD1L1 SIPA1L2 TNPO3 ANKS1A | 1.14e-05 | 1248 | 176 | 27 | int:YWHAG |
| Interaction | CTAGE8 interactions | 1.28e-05 | 6 | 176 | 3 | int:CTAGE8 | |
| Interaction | SYNGAP1 interactions | PDGFRB KTN1 SRGAP2 CEP170 CCDC88A MTOR SRGAP1 CEP250 SYN1 SIPA1L2 HOMER1 ANKS1A | 1.71e-05 | 307 | 176 | 12 | int:SYNGAP1 |
| Interaction | PCM1 interactions | FILIP1 EPS8 ACOT9 USP28 CNOT10 CEP290 KIAA0586 ANKRD26 SRGAP2 CEP170 SPC24 TXLNA SRGAP1 CEP250 | 2.91e-05 | 434 | 176 | 14 | int:PCM1 |
| Interaction | EMILIN1 interactions | 3.37e-05 | 103 | 176 | 7 | int:EMILIN1 | |
| Interaction | LATS1 interactions | ATP5PB TET2 MYH3 TNC CEP290 ANKRD26 TAB3 CCDC88C CCDC88A MDN1 XIRP2 MYOM2 SIPA1L2 MVP | 3.38e-05 | 440 | 176 | 14 | int:LATS1 |
| Interaction | CLIP1 interactions | 3.41e-05 | 183 | 176 | 9 | int:CLIP1 | |
| Interaction | MAPRE3 interactions | FILIP1 CENPF FCHO1 CEP170 IARS2 CCDC88A DST PDE4DIP MARF1 MACF1 | 3.58e-05 | 230 | 176 | 10 | int:MAPRE3 |
| Interaction | DSCR9 interactions | 4.58e-05 | 147 | 176 | 8 | int:DSCR9 | |
| Interaction | MIA2 interactions | 6.10e-05 | 113 | 176 | 7 | int:MIA2 | |
| Interaction | GSK3B interactions | DNAJC13 KIAA0586 BPIFB1 CREM HELB NUP205 IARS2 UBA1 CCDC88A TBC1D4 DST USO1 MTOR SERPINB4 MACF1 CHD6 SIPA1L2 MVP GOLGA3 ANKS1A | 7.42e-05 | 868 | 176 | 20 | int:GSK3B |
| Interaction | YWHAZ interactions | TET2 UAP1 HIVEP1 ANKRD26 SRGAP2 TRIM3 TAB3 CEP170 CCDC88C TXLNA UBA1 CCDC88A TBC1D4 DST PTPRO MTOR SRGAP1 MDC1 SYN1 MACF1 RAI14 SIPA1L2 HOMER1 NXF1 GOLGA3 ANKS1A | 8.11e-05 | 1319 | 176 | 26 | int:YWHAZ |
| Interaction | ST8SIA4 interactions | 9.42e-05 | 84 | 176 | 6 | int:ST8SIA4 | |
| Interaction | QPRT interactions | 9.42e-05 | 84 | 176 | 6 | int:QPRT | |
| Interaction | FBXO42 interactions | 9.68e-05 | 259 | 176 | 10 | int:FBXO42 | |
| Interaction | RCOR1 interactions | SOX5 DNAJC13 HIVEP1 CENPF SPAG9 CCDC88A DST GSE1 CTBP1 RAI14 CHD6 NXF1 GOLGA3 KNL1 | 1.16e-04 | 494 | 176 | 14 | int:RCOR1 |
| Interaction | RCOR3 interactions | 1.38e-04 | 172 | 176 | 8 | int:RCOR3 | |
| Interaction | HERC2 interactions | CDK12 TNIP2 KTN1 CEP290 APBA2 SRGAP2 CEP170 CCDC88A DST DNAJC28 CEP250 MDC1 MACF1 USP33 | 1.40e-04 | 503 | 176 | 14 | int:HERC2 |
| Interaction | CEP135 interactions | CEP290 ANKRD26 TOGARAM1 CEP170 CCDC88C TXLNA CCDC88A GSE1 CEP250 SIPA1L2 | 1.45e-04 | 272 | 176 | 10 | int:CEP135 |
| Interaction | NUP62 interactions | GOPC TNIP2 NUP205 TXLNA CCDC88A USO1 CEP250 RGPD3 CTBP1 NXF1 | 1.49e-04 | 273 | 176 | 10 | int:NUP62 |
| Interaction | H2BC9 interactions | HIVEP1 CEP290 BAZ1B SPAG9 ZNF385B CCDC88C TBC1D4 DST XIRP2 MDC1 PDE4DIP CCDC89 MVP | 1.55e-04 | 446 | 176 | 13 | int:H2BC9 |
| Interaction | C6orf141 interactions | 1.56e-04 | 92 | 176 | 6 | int:C6orf141 | |
| Interaction | MED4 interactions | ATP5PB CNOT10 CEP290 ANKRD26 SPAG9 CEP170 SPC24 TXLNA DST SMARCD1 RAI14 HOMER1 NXF1 | 1.70e-04 | 450 | 176 | 13 | int:MED4 |
| Interaction | MAPRE1 interactions | CNOT10 KTN1 CEP290 ANKRD26 BAZ1B FCHO1 NUP205 CEP170 CCDC88A DST CEP250 PDE4DIP MACF1 NXF1 | 1.76e-04 | 514 | 176 | 14 | int:MAPRE1 |
| Interaction | SCN2B interactions | 1.86e-04 | 95 | 176 | 6 | int:SCN2B | |
| Interaction | NINL interactions | CNOT10 TNIP2 CEP290 ANKRD26 MIPOL1 CEP170 CCDC88C TXLNA UBA1 TBC1D4 GSE1 CEP250 SIPA1L2 | 2.01e-04 | 458 | 176 | 13 | int:NINL |
| Interaction | KDM1A interactions | ATP5PB TET2 DNAJC13 HIVEP1 CENPF USP28 LIN54 CCDC88A TBC1D4 DST GSE1 USO1 PDE4DIP SMARCD1 CTBP1 RAI14 CHD6 NXF1 GOLGA3 KNL1 | 2.19e-04 | 941 | 176 | 20 | int:KDM1A |
| Interaction | FMNL2 interactions | 2.27e-04 | 185 | 176 | 8 | int:FMNL2 | |
| Interaction | GSK3A interactions | KIAA0586 CREM HELB CCDC88A TBC1D4 SNW1 DST MDN1 USO1 MACF1 SIPA1L2 GOLGA3 ANKS1A | 2.28e-04 | 464 | 176 | 13 | int:GSK3A |
| GeneFamily | CTAGE family | 2.12e-10 | 15 | 110 | 6 | 907 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 2.18e-04 | 4 | 110 | 2 | 1332 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 3.55e-04 | 23 | 110 | 3 | 1288 | |
| GeneFamily | MTOR complex 1|MTOR complex 2 | 3.62e-04 | 5 | 110 | 2 | 1333 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.00e-03 | 8 | 110 | 2 | 939 | |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 1.04e-06 | 198 | 177 | 10 | M2077 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS8 DNAJC13 HIVEP1 CENPF BAZ1B TOGARAM1 SPAG9 SRGAP2 CEP170 SETD2 SNW1 DST MDN1 MIA2 GSE1 TUBGCP3 MACF1 SLC16A7 HOMER1 ANKS1A | 1.51e-06 | 856 | 177 | 20 | M4500 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 3.95e-06 | 180 | 177 | 9 | M8239 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 CTAGE9 QRICH1 PTGFRN CDC37L1 TXLNA SNW1 MIA2 CTAGE1 CTAGE8 CTBP1 SIPA1L2 PCDH18 BAHCC1 | 5.75e-06 | 484 | 177 | 14 | MM999 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | DNAJC13 GOPC CENPF TNC SRGAP2 CHML DNTTIP2 TAB3 MIPOL1 LIG4 CCDC88A STC2 USO1 TUBGCP3 BOD1L1 KNL1 BRWD1 | 8.55e-06 | 721 | 177 | 17 | M10237 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | EPS8 DNAJC13 HIVEP1 CENPF SRGAP2 CEP170 SETD2 DST MDN1 TUBGCP3 MARF1 HOMER1 ANKS1A | 1.83e-05 | 466 | 177 | 13 | M13522 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 1.86e-05 | 81 | 177 | 6 | M39253 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | FILIP1 SPAG9 DNTTIP2 AKAP12 NRP2 CEP170 STC2 SRGAP1 MACF1 RAI14 | 3.45e-05 | 295 | 177 | 10 | M39121 |
| Coexpression | CHEN_LIVER_METABOLISM_QTL_CIS | 4.60e-05 | 95 | 177 | 6 | M1947 | |
| Coexpression | CHEN_LIVER_METABOLISM_QTL_CIS | 5.80e-05 | 99 | 177 | 6 | MM827 | |
| Coexpression | TERAO_AOX4_TARGETS_HG_UP | 6.23e-05 | 32 | 177 | 4 | MM922 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN | 6.77e-05 | 200 | 177 | 8 | M6045 | |
| Coexpression | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP | 8.94e-05 | 35 | 177 | 4 | M11954 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RETREG2 CENPF ZNF180 LIN54 KTN1 CEP290 KIAA0586 ANKRD26 BAZ1B PLXNB2 CDC37L1 SETD2 AIFM2 CCDC88A SRGAP1 CEP250 FGD1 SYN1 BOD1L1 MLST8 STX17 GOLGA3 KNL1 | 4.59e-07 | 831 | 177 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RETREG2 CENPF ZNF180 LIN54 CEP290 KIAA0586 ANKRD26 BAZ1B PLXNB2 CDC37L1 SETD2 AIFM2 CCDC88A SRGAP1 CEP250 MARF1 FGD1 MACF1 MLST8 SIPA1L2 STX17 GOLGA3 | 6.09e-07 | 780 | 177 | 22 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SOX5 CENPF LIN54 KTN1 CEP290 KIAA0586 ANKRD26 BAZ1B CHML UBN2 ZRANB3 DNTTIP2 CCDC88C LIG4 AIFM2 IARS2 CCDC88A MDN1 MDC1 ST8SIA2 MACF1 BOD1L1 ZNF761 RNF128 HOMER1 KNL1 BRWD1 | 5.66e-06 | 1257 | 177 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | RBM44 DNAJC13 CENPF CDK12 ANKRD26 ZRANB3 TAB3 MDN1 MTOR MDC1 HCFC1 BRWD1 | 5.32e-05 | 361 | 177 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | CCDC170 SEMA4D RBM44 DNAJC13 CENPF CDK12 USP28 KIAA0586 TEX11 ZRANB3 TAB3 HELB NUP205 MDN1 SLCO4C1 MTOR FGD1 HCFC1 BRWD1 | 5.94e-05 | 822 | 177 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SOX5 CENPF LIN54 KTN1 CEP290 KIAA0586 ANKRD26 BAZ1B CHML UBN2 ZRANB3 DNTTIP2 CCDC88C LIG4 AIFM2 IARS2 CCDC88A MDN1 MDC1 ST8SIA2 MACF1 BOD1L1 ZNF761 RNF128 HOMER1 KNL1 BRWD1 | 7.76e-05 | 1459 | 177 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.57e-08 | 184 | 177 | 9 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.01e-08 | 189 | 177 | 9 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-08 | 191 | 177 | 9 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.67e-08 | 191 | 177 | 9 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.39e-08 | 193 | 177 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 9.16e-08 | 195 | 177 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.09e-07 | 199 | 177 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.14e-07 | 200 | 177 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-07 | 170 | 177 | 8 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.42e-07 | 176 | 177 | 8 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 177 | 177 | 8 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-07 | 177 | 177 | 8 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.91e-07 | 178 | 177 | 8 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 6.16e-07 | 179 | 177 | 8 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.70e-07 | 181 | 177 | 8 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.70e-07 | 181 | 177 | 8 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | Control-Epithelial-Club|Epithelial / Disease state, Lineage and Cell class | 7.91e-07 | 185 | 177 | 8 | 6814b3c94c7558443c038a227b5c8563d2cfeac4 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.91e-07 | 185 | 177 | 8 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 9.66e-07 | 190 | 177 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.01e-06 | 191 | 177 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 191 | 177 | 8 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 191 | 177 | 8 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-06 | 192 | 177 | 8 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 192 | 177 | 8 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.13e-06 | 194 | 177 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-06 | 195 | 177 | 8 | 0792c1e959e933b10ae987d821ff43020dfdabad | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-06 | 196 | 177 | 8 | 01cea0bb0b938d0986fd2ddae06597b8af1768ee | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 197 | 177 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 197 | 177 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.32e-06 | 198 | 177 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.42e-06 | 200 | 177 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.56e-06 | 175 | 177 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.81e-06 | 176 | 177 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 177 | 177 | 7 | e8bb4f8ecd5e283efec966b9fc2040a6152d5551 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 8.48e-06 | 182 | 177 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 8.79e-06 | 183 | 177 | 7 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 184 | 177 | 7 | 72b42dfca7e9c0257f11d8242531e843271871a7 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 184 | 177 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 9.10e-06 | 184 | 177 | 7 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.10e-06 | 184 | 177 | 7 | c6f4537ae8b6e8fde1be17df14629b7b49b4997c | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.43e-06 | 185 | 177 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 186 | 177 | 7 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | 0ffb988e0da2c7205c3515eca8e9851739bff5c5 | |
| ToppCell | facs-Heart-Unknown|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | 362e56426a568423a81e8a30e3ecf99b76135843 | |
| ToppCell | facs-Heart-Unknown-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 187 | 177 | 7 | c004567767b89f3d89f5c7b28d952f3445957e1e | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 188 | 177 | 7 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 188 | 177 | 7 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 189 | 177 | 7 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 189 | 177 | 7 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 190 | 177 | 7 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.12e-05 | 190 | 177 | 7 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 190 | 177 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 1.12e-05 | 190 | 177 | 7 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-05 | 191 | 177 | 7 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 191 | 177 | 7 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-05 | 191 | 177 | 7 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 192 | 177 | 7 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 192 | 177 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 192 | 177 | 7 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 193 | 177 | 7 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.24e-05 | 193 | 177 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 1.28e-05 | 194 | 177 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 194 | 177 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.28e-05 | 194 | 177 | 7 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 194 | 177 | 7 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.28e-05 | 194 | 177 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 195 | 177 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 195 | 177 | 7 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 196 | 177 | 7 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-05 | 197 | 177 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-05 | 197 | 177 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.42e-05 | 197 | 177 | 7 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-05 | 198 | 177 | 7 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 198 | 177 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-05 | 198 | 177 | 7 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.46e-05 | 198 | 177 | 7 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.46e-05 | 198 | 177 | 7 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 1.51e-05 | 199 | 177 | 7 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.51e-05 | 199 | 177 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.51e-05 | 199 | 177 | 7 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 1.51e-05 | 199 | 177 | 7 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 133 | 177 | 6 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 133 | 177 | 6 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 200 | 177 | 7 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 200 | 177 | 7 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.56e-05 | 200 | 177 | 7 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 177 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 177 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.56e-05 | 200 | 177 | 7 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 41 | 177 | 4 | 9f609afcf34f0b486dfe51e5f0e903fe357d3e91 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.16e-05 | 151 | 177 | 6 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; HL60; HT_HG-U133A | SYNE1 ANKRD26 ELP1 ECE1 CHML CDC37L1 ME3 MIA2 PTPRO SMARCD1 SLC16A7 BRWD1 | 4.31e-08 | 197 | 175 | 12 | 2569_DN |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | CEP290 APBA2 ALPK1 ECE1 TRIM3 CCDC88A TBC1D4 MTOR PDE4DIP SMARCD1 | 3.25e-06 | 198 | 175 | 10 | 6388_DN |
| Drug | Clorgyline | 6.32e-06 | 168 | 175 | 9 | ctd:D003010 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | SEMA4D CREM TRIM3 CCDC88C TUBGCP3 PDE4DIP SMARCD1 SLC16A7 HCFC1 | 1.93e-05 | 193 | 175 | 9 | 1022_DN |
| Drug | Budesonide [51333-22-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.09e-05 | 195 | 175 | 9 | 6330_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.26e-05 | 197 | 175 | 9 | 3639_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; HL60; HG-U133A | 2.26e-05 | 197 | 175 | 9 | 2034_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | CEP290 KIAA0586 ANKRD26 TRIM3 VPS9D1 RNASEL MIA2 PDE4DIP FGD1 | 2.36e-05 | 198 | 175 | 9 | 1491_DN |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; PC3; HT_HG-U133A | 2.36e-05 | 198 | 175 | 9 | 6681_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 2.45e-05 | 199 | 175 | 9 | 3341_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.45e-05 | 199 | 175 | 9 | 3280_UP | |
| Disease | myeloproliferative neoplasm (is_implicated_in) | 1.85e-04 | 4 | 165 | 2 | DOID:2226 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | XIRP1 CENPF SYNE1 KTN1 OBSCN ELP1 AKAP12 BMP2 SETD2 MIA2 STC2 MTOR SMARCD1 MACF1 TEKT4 BOD1L1 | 3.63e-04 | 1074 | 165 | 16 | C0006142 |
| Disease | Leukemia, Myelomonocytic, Chronic | 4.59e-04 | 6 | 165 | 2 | C0023480 | |
| Disease | Lissencephaly | 4.59e-04 | 6 | 165 | 2 | C0266463 | |
| Disease | prostate cancer (is_implicated_in) | 5.21e-04 | 117 | 165 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | T-cell immunoglobulin and mucin domain 1 measurement | 6.41e-04 | 7 | 165 | 2 | EFO_0010812 | |
| Disease | hair colour measurement | SOX5 ASIC2 APBA2 CHCHD6 PLXNB2 AKAP12 VPS9D1 THRB RAI14 SIPA1L2 STX17 | 7.21e-04 | 615 | 165 | 11 | EFO_0007822 |
| Disease | urate measurement, bone density | ASIC2 SYNE1 LIN54 AOAH QRICH1 ABCA8 AKAP12 GSE1 USO1 ST8SIA2 CTNNA2 | 7.60e-04 | 619 | 165 | 11 | EFO_0003923, EFO_0004531 |
| Disease | wellbeing measurement, alcohol consumption measurement | 8.00e-04 | 74 | 165 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | Intellectual Disability | 9.71e-04 | 447 | 165 | 9 | C3714756 | |
| Disease | oppositional defiant disorder measurement | 1.07e-03 | 36 | 165 | 3 | EFO_0007679 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.07e-03 | 80 | 165 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | tooth agenesis (is_implicated_in) | 1.36e-03 | 10 | 165 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.36e-03 | 10 | 165 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 1.65e-03 | 11 | 165 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | Uterine leiomyoma | 1.73e-03 | 91 | 165 | 4 | HP_0000131 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.98e-03 | 12 | 165 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.33e-03 | 13 | 165 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.33e-03 | 13 | 165 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | blood phosphate measurement | 3.02e-03 | 174 | 165 | 5 | EFO_0010972 | |
| Disease | monokine induced by gamma interferon measurement | 3.10e-03 | 52 | 165 | 3 | EFO_0008236 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.11e-03 | 15 | 165 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 3.40e-03 | 538 | 165 | 9 | C0678222 | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 3.46e-03 | 54 | 165 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | platelet component distribution width | SYNE1 LIN54 TEX11 VPS9D1 SETD2 THRB MIA2 GSE1 MACF1 ANKS1A BRWD1 | 3.60e-03 | 755 | 165 | 11 | EFO_0007984 |
| Disease | Polydactyly | 4.28e-03 | 117 | 165 | 4 | C0152427 | |
| Disease | renal agenesis, unilateral | 4.87e-03 | 61 | 165 | 3 | MONDO_0019636 | |
| Disease | Chronic myeloproliferative disorder | 4.99e-03 | 19 | 165 | 2 | C1292778 | |
| Disease | cerebral microbleeds | 4.99e-03 | 19 | 165 | 2 | EFO_0010059 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 4.99e-03 | 19 | 165 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | uterine fibroid | 5.33e-03 | 199 | 165 | 5 | EFO_0000731 | |
| Disease | Osteoarthritis of hip | 5.53e-03 | 20 | 165 | 2 | C0029410 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | SOX5 TET2 HIVEP1 ASIC2 USP28 ELP1 CTBP1 CTNNA2 SIPA1L2 GOLGA3 BRWD1 | 5.57e-03 | 801 | 165 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NAQVFEVTIKIVNHN | 396 | Q5DID0 | |
| QKVQATEKHQDQAVT | 411 | Q5SW79 | |
| AQISVTLVNHSEQEK | 491 | P16452 | |
| TLVNHSEQEKAVQLA | 496 | P16452 | |
| DENDVQTISHKCQVV | 2581 | Q9P281 | |
| TAVTQQVQNDAEIKH | 196 | Q6P093 | |
| ELVNVTHLNTEVKNS | 461 | Q9NYV4 | |
| QQAVEQIAKAEETHS | 241 | Q8N998 | |
| TQELKDHNATSILQQ | 41 | Q8TDL5 | |
| AQSTQEIHEKVLNEA | 56 | Q13363 | |
| TEHIKNLQTEQASLQ | 321 | Q96RT6 | |
| ELTEHIKNLQTQQAS | 351 | Q8IX94 | |
| ELTEHIKNLQTQQAS | 351 | P0CG41 | |
| ELTEHIKNLQTQQAS | 351 | A4FU28 | |
| ELTEHIKNLQTQQAS | 351 | A4D2H0 | |
| QHTQTQDLQVFLKEE | 1206 | Q96NH3 | |
| LQTQAHVIKADSQDA | 1576 | Q02952 | |
| NATTVQHEVFNVVNI | 226 | O43506 | |
| SSQIAQDHQKKETVV | 166 | Q9UIG0 | |
| QQHTQELFISNITEK | 456 | P06731 | |
| VAVLSAEQNHKVDTS | 1046 | Q14687 | |
| EVASLQEKQHTTTNV | 376 | Q9Y305 | |
| QSVVATAHEKIVQAL | 706 | Q99767 | |
| SNKNVIAEHEIRNIS | 996 | Q92625 | |
| SAQEHLASLQEQVAV | 436 | Q8TF21 | |
| EKTVINIQDQFHAIV | 1161 | Q9UPS8 | |
| TLESKNTQNDFEVHI | 296 | Q99674 | |
| NHAIVQTLVNSVNSK | 341 | P12643 | |
| EEAKQASIQHIQNAI | 136 | P24539 | |
| ASIQHIQNAIDTEKS | 141 | P24539 | |
| VIAQVKEHLQVQSFS | 411 | Q96QP1 | |
| IVSSEKDHTQANIQA | 46 | Q7Z4T9 | |
| QHVTKVDEVVAQSLV | 71 | Q16515 | |
| NEHAVKQAETLFQEI | 586 | P26374 | |
| DAQKENSVSITEHLQ | 721 | Q9P0K7 | |
| NHQVSEVFNTVAQEL | 166 | Q9H0T7 | |
| NQAIEDNTSLKVAHS | 421 | Q6ZP01 | |
| SVVKNSHEEVVQTLA | 366 | Q2TAL8 | |
| SVSQINHKLEAQLVD | 86 | Q9HD26 | |
| VQQHEKVQKASTEGV | 61 | Q92621 | |
| STVKHFTVQINDIND | 446 | Q9HCL0 | |
| EHNITVLVSDVNDNA | 436 | Q9Y5E7 | |
| EHNITVLVSDVNDNA | 381 | Q96TA0 | |
| HIEVQVAQETRNVST | 316 | O60271 | |
| IEQLAQVHNSTVQAS | 51 | P28039 | |
| QVHEEFKQNIENVSV | 231 | O14526 | |
| HKSGTVTVAQQAQVV | 636 | P51610 | |
| VAFNNQIDHEVTVEK | 1921 | Q9NU22 | |
| NHTNQVAVNTTITKA | 71 | Q6MZP7 | |
| HQVSVEGTNQTDVKA | 541 | Q14676 | |
| QHAREASQVANEKVQ | 406 | Q8TD10 | |
| QEVQSSAKEVTQLRH | 361 | P35527 | |
| DVLAHQSTVEAVNKA | 6426 | Q03001 | |
| VNEHITNVNVESNFI | 266 | Q6P5Q4 | |
| VAHIQEVTHNQENVF | 156 | Q9P219 | |
| EQVAFKEHALAVQVQ | 426 | Q9UL16 | |
| VAAHIQEVTHNQENV | 156 | Q3V6T2 | |
| RTVQHQDSQVNALEV | 36 | Q9BVC4 | |
| NLTAVTVAAENNHTV | 391 | O15031 | |
| KTQHDVNSFVVDISA | 471 | Q9UBU9 | |
| HKVFQANNDATEVVL | 381 | O60462 | |
| ANNDATEVVLNKLHA | 386 | O60462 | |
| KVLSHVIEQTNASQS | 101 | Q9NX36 | |
| HSEDVNVKVSNAQSV | 456 | O60669 | |
| KNQIISATTSNAHVV | 146 | Q7Z3Y8 | |
| LSQIEEHKVFANEVN | 2606 | O94854 | |
| VQEVAQHNLKEASSA | 911 | Q86UP2 | |
| HTVAIDNQIFKQDQS | 516 | Q8NG31 | |
| LDFHSNSDVTKQVIQ | 1546 | Q8NG31 | |
| NSDVTKQVIQTHVNA | 1551 | Q8NG31 | |
| ENQARTHVLSKEVQH | 236 | Q96CN5 | |
| NKVQQAQDLDHIIAA | 736 | Q96CW5 | |
| NVETFIKQIDSVNHI | 766 | O95163 | |
| DKQSVHIVENEIQAS | 26 | O14653 | |
| IKDVLQAAAAEHQDQ | 361 | Q08378 | |
| KHSQEIAQFQAELAE | 1246 | Q08378 | |
| QHQIKEVLASSQEAL | 46 | Q9H772 | |
| ATKVIAAQAQQAHVQ | 91 | Q9H422 | |
| AVHTHKTELNQTIQE | 241 | Q86YM7 | |
| AIEITTNSQEAAAKH | 661 | Q14764 | |
| NDVLAHQATVETVNK | 6271 | Q9UPN3 | |
| NTVLSQIEEHKVFAN | 6476 | Q9UPN3 | |
| HVTVQDDNNIVVSLE | 31 | Q16827 | |
| FAKEQSVHNEVQAEA | 1166 | Q5VST9 | |
| LKTEHNITVQISDVN | 431 | Q9NRJ7 | |
| QEQEVSAANVEHLKN | 1701 | A6NKT7 | |
| LAVHAVKIEANVNSV | 1631 | Q8NFC6 | |
| QHTEKASQLQTVETA | 36 | Q9HBI5 | |
| NHVVQNEKSDTHTLV | 186 | O60725 | |
| TIDNEKNTAIINIHA | 41 | Q86XP6 | |
| KAHVLAASVEQATQN | 56 | P26232 | |
| TQAHTKNEVIDALNE | 406 | P49917 | |
| ISHELQVKESQVNFQ | 86 | P49454 | |
| SKLQEDTSAHQNVVA | 886 | P49454 | |
| NFISKVQDVISINHD | 1681 | Q8TD26 | |
| ATSQKEAHLNVQQIV | 1766 | O15078 | |
| AALQQVVHNKSLVTA | 991 | Q5JV73 | |
| ENLTAQVEHLQAAVV | 1351 | Q9BV73 | |
| QNDSIVVTAVNDHVL | 436 | Q9NSI6 | |
| QQEVANSLAKLSVHA | 1571 | O75165 | |
| QTQLAEVTIACKVNH | 206 | Q6ZN28 | |
| QVTVAHINATAKNAA | 411 | Q9Y4F3 | |
| TAEQIAQEVSEQHLS | 516 | Q16798 | |
| LQHATQVAEEAVQQK | 596 | Q9NQR7 | |
| LESNAVIENKTIAHN | 471 | Q8IYT3 | |
| LAESVANVAEHQRKQ | 456 | Q12929 | |
| AKDNFQDTLQVVTAH | 216 | P42892 | |
| QSSEIHTVQVAAIAE | 81 | Q03060 | |
| TIQDVQNQAVKKATH | 526 | Q96S37 | |
| VKTHLQAQAASEIAV | 126 | Q3KQZ1 | |
| LNVNNTEHVVSIVTD | 706 | Q8IZU8 | |
| KTNHRAESQLIVDNA | 651 | Q8NG08 | |
| QEHAKAQTAVSELRQ | 91 | Q7L3B6 | |
| SVNDHQDEKAINITV | 296 | P09619 | |
| HIKNLQTEQASLQSE | 961 | Q96PC5 | |
| AHVVSQTAVQVVADV | 641 | P42345 | |
| RTANDAVELHIKNVQ | 96 | Q9P2B2 | |
| KVDNQHDFQDIASVV | 281 | P17600 | |
| AVALAHALQENATQK | 441 | O60763 | |
| HNNCEKDSVIVSIIN | 296 | Q695T7 | |
| QVAEAVLTSQLKAHQ | 36 | P49590 | |
| DQVSCQAHVNEIIKT | 671 | Q7Z6B7 | |
| TASQQEIATLDNKIH | 411 | Q96GM5 | |
| QVIQKALSDAQSHVN | 4421 | Q8NF91 | |
| VTSKVQADIHDTQAA | 646 | Q8N5C8 | |
| NANIITTEDNKIHIH | 1056 | Q7Z7B0 | |
| HANIAVANIVNSVKQ | 301 | Q9BRQ8 | |
| EQEHAAIQDKLFQVA | 91 | Q9BRQ6 | |
| RAAKVVQEAHQQTLD | 1006 | Q9Y2K3 | |
| VELTVQQKVFHIANE | 366 | P98174 | |
| DIHSLVQSDQEAQAV | 526 | Q8NC44 | |
| ESLQLVNHEANSVAV | 386 | Q8TEB7 | |
| AAVEDNHLLIKAVQN | 21 | Q05823 | |
| TQHQTVVGDAVAETQ | 1431 | Q9P2F8 | |
| AVVDRSNESIKHNIQ | 66 | Q92186 | |
| EITDQEHNVAALKQA | 316 | Q8WW24 | |
| QTVDQVHHAVNALSK | 416 | P11055 | |
| NSQTTEHIVKLVEQH | 546 | Q9NSE4 | |
| FAVNALNISEKQHEV | 71 | Q92854 | |
| QAAINAAIIEITTNH | 181 | O94911 | |
| IESNSSKIQSQIDHI | 126 | Q8NHS4 | |
| SVVQKSTNVEELHQS | 96 | Q5U649 | |
| TLNQLKNQVHSAVEE | 86 | Q9H9A5 | |
| NILTVHEQANVESLK | 276 | Q5QJE6 | |
| HTSVQSVIEKLQEEN | 196 | Q8NFZ5 | |
| KVIDAHLDSQTQNFQ | 2681 | A4UGR9 | |
| AHIKASHNNTQIQVV | 86 | P82912 | |
| DNQVVKSVHDASLVS | 161 | Q86XN6 | |
| EAQDASSLTQVTKVH | 916 | Q6ZU65 | |
| EVAQSLLNAKEQVHQ | 61 | Q8NBT2 | |
| FHKENAVVTNVLAEQ | 701 | Q6ZQN7 | |
| QQEKIDSIADHVNSA | 196 | P56962 | |
| ETVAVSVHFQDQNDV | 1441 | O94759 | |
| KEAITHSVQVQCEQN | 186 | O76061 | |
| AVSAVANVNDVHQAT | 126 | Q8TAV4 | |
| DQVSCQAHVNELIKT | 656 | O75044 | |
| LIKTVTEAHVATNAQ | 221 | P10828 | |
| HFVIQVQEVNKVEAA | 1376 | P24821 | |
| AQHSEDQEQVLTAVK | 566 | Q8IYF3 | |
| QQISKVLHFDQVTEN | 51 | P48594 | |
| QTVHINENFAKLAEA | 276 | Q13573 | |
| SEHAVIVKEQTAQAI | 736 | Q96RU2 | |
| VTHDQAVVLQSALQS | 1191 | O00507 | |
| KVAVNSLSQLEAHNT | 291 | Q569K4 | |
| KIHVSDQELQSANAS | 806 | P22314 | |
| QVAHTKIQALESNLE | 1221 | O60343 | |
| ETITADVNHNLKDAN | 461 | Q16222 | |
| HVTQILNEQADISSK | 266 | Q9BYW2 | |
| VLQQDKTSSNLHEAA | 231 | Q9Y5L0 | |
| AAVNSHQKINENETL | 231 | Q9UJW8 | |
| IVSDNSSNVVHAIKD | 561 | P86452 | |
| LTENNQTDKAQVHAV | 141 | A8MUA0 | |
| DTKEVQQHALIHQES | 616 | P17010 | |
| NDHDAVTKAIQEARQ | 451 | P35711 | |
| AATNVVQALSQHVDN | 1591 | Q9Y4F4 | |
| QQLKTAVEEIHNAVD | 406 | Q9Y2B5 | |
| AVQKTTSHINAINSQ | 241 | Q6N021 | |
| ATAEAQSLHQQVLNK | 1061 | Q702N8 | |
| QTAVKNQAKVECHTE | 1606 | Q702N8 | |
| TLHSQTQVKDLQAET | 1481 | P15822 | |
| QSSAKVEVHFNDQVE | 341 | Q5QJ74 | |
| NQETVKVQIHSRASE | 396 | Q8TEY7 | |
| NSNVIKHFVNEALAE | 986 | Q9BVV6 | |
| HFVAVNNKNEIVVTD | 626 | O75382 | |
| KEVTSHFQVTLNDIQ | 271 | P40222 | |
| SDTKEVQQHTLVHQE | 611 | P08048 | |
| LNNQNFKVVIVDESH | 146 | Q5FWF4 | |
| NDQDIQLSEHFSVKV | 1381 | P54296 | |
| VQFVEAAAHESEQQK | 376 | Q5VU43 |